We understand that you’re starving for some good news and because the word ‘vaccine’ is the most appealing this year, we have gathered most of the information and updates you need to know regarding finding a vaccine for COVID-19.
So yes, all what follows are good news aimed at lifting up your spirits.
1st Clinical Test in Japan of Coronavirus Vaccine to Start June 30

A clinical test of a potential vaccine for the new coronavirus developed by medical startup Anges Inc. will start on June 30 in Japan, Osaka Gov. Hirofumi Yoshimura made the announced yesterday, hoping that it can be put it into practice next year.
“I think it will be the first clinical test (of a coronavirus vaccine) on humans in Japan,” Yoshimura told a press conference.
So when can we expect it? Yoshimura said it is possible to produce the DNA vaccine for 200,000 people by the end of this year and they are applying for state approval between spring and fall of next year, if of course the human trial proves its effectiveness in preventing COVID-19 infection.
China’s COVID-19 Vaccine Candidate Shows Promise in Human Trials

China National Biotec Group (CNBG) announced on Tuesday that its experimental coronavirus vaccine has succeeded in triggering antibodies in clinical trials and that the company is planning the late-stage human trials in foreign countries.
The vaccine has been developed by a Wuhan-based research institute affiliated to CNBG’s parent company China National Pharmaceutical Group (Sinopharm).
It was found to have induced high-level antibodies in all inoculated people without serious adverse reaction, according to the preliminary data from a clinical trial initiated in April which included 1,120 healthy participants aged between 18 and 59.
UAE Stem Cell Treatment Makes ‘Positive’ Progress In Helping To Cure COVID-19

The UAE is joining in the battle against the virus! It’s not a vaccine but a treatment which is just as good.
Arabian Business reported that stem cell treatment for patients suffering from the virus has shown “positive” results, according to Dr. Fatima Al Kaabi, consultant and head of Hematology and Oncology Department at Sheikh Khalifa Medical City, and senior specialist in research related with the stem cell project.
The treatment was given to 73 individuals with mild and moderate symptoms.
67 percent of patients of those who received stem cell therapy for the virus have been cured, with improvements in condition occurring after four days after the treatment was administered.
“All the patients who were treated with stem cells, recovered in less than seven days, three times faster than those treated with conventional methods,” Dr Al Kaabi said, according to Arabian Business.
Egypt Signs Deal to Receive Japan’s Avigan and Attempting To Get Oxford University Vaccine

Where does Egypt stand in all of this? Egypt signed a deal to receive Japan’s Avigan and is attempting to get the vaccine developed at Oxford University.
Avigan helps in accelerating the recovery of patients and Egypt is exerting efforts to get a share of the vaccine developed by Oxford University.